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Fluidity Properties and Lipid Composition of Erythrocyte
Membranes in Chediak-Higashi Syndrome
ABSTRACT
￿
We have earlier shown through electron spin resonance (ESR) studies of leukocytes
that membranes of cells from both Chediak-Higashi syndrome (CHS) mice and humans have
abnormally high fluidity. We have extended our studies to erythrocytes . Erythrocytes were
labeled with the nitroxide-substituted analogue of stearic acid, 2-(3-carboxypropyl)-4,4-di-
methyl-2-tridecyl-3-oxazolidinyloxyl, and ESR spectra were obtained. Order parameter, S, at
23°C, was 0.661 and 0.653 for erythrocytes of normal and CHS mice (P < 0.001). S was 0.684 for
normal human erythrocytes and 0.675 (P < 0.001) for CHS erythrocytes at 25°C. Because S
varies inversely to fluidity, these results indicate that CHS erythrocytes tend to have higher
fluidity than normal . In vitro treatment of both mice and human CHS erythrocytes with 10 mM
ascorbate returned their membrane fluidity to normal. We prepared erythrocyte ghosts and
extracted them with CHC13:CH3OH (2 :1). Gas-liquid chromatography analysis showed a greater
number of unsaturated fatty acids for CHS. The average number of double bonds detected in
fatty acids for mice on a standard diet was 1.77 for normal and 2.02 for CHS (P < 0.04) ;
comparison of human erythrocytes from one normal control and one CHS patient showed a
similar trend. Our results suggest that an increased proportion of unsaturated fatty acids may
contribute to increased fluidity of CHS erythrocytes. Our observation that both leukocytes and
erythrocytes of CHS have abnormal fluidity indicates that CHS pathophysiology may relate to
a general membrane disorder.
The Chediak-Higashi syndrome (CHS) is an autosomal reces-
sive genetic disease that has been reported in man and mice as
well as a variety of other mammalian species (3, 32). Charac-
teristic of this disorder is the presence of enlarged granules in
many cells, particularly the melanocytes and the polymorpho-
nuclear leukocytes (PMN). Some phenotypic characteristicsof
the syndrome are reflections of these abnormal granules: a
partial oculocutaneous albinism resulting from aggregation of
melanin granules and an increased susceptibility to bacterial
infection partly resulting from defective degranulation in PMN
after phagocytosis.
The giant granules of the PMN appear to arise from the
abnormal fusion of enlarged primary granules with normal
secondary granules (34, 36), suggesting that membrane altera-
tions may be a fundamental defect of CHS. This hypothesis is
supported by observations that CHS PMN are impaired not
only in degranulation but also in plasma membrane-mediated
events of central importance in phagocytic function: chemo-
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taxis (13) and adherence (5). Further, unlike normal PMN
membrane, concanavalin A (Con A) receptors of the CHS
PMN membrane undergo spontaneous capping when the cells
are incubated with the lectin (30), suggesting a greater than
normal mobility of membrane glycoproteins. Recently, we
examined the membrane fluidity characteristics of PMN from
both CHS and normal mice and humans through use of
electron spin resonance (ESR) techniques. We showed that
spin-label analogues of stearic acid appeared to have greater
freedom of molecular movement in membranes of CHS cells
than in membranes of normal PMN (21).
We wished to evaluate the possibility that abnormal lipid
composition mightunderlie the increased fluidity ofCHS PMN
membrane. Techniques are available for preparation of PMN
membrane fractions enriched for plasma membrane markers
(41), but a fraction trulyrepresentative ofplasma membrane is
not readily obtainable (44). Because the membranes of eryth-
rocytes are readily prepared, we turned our attention to these
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for other pathological conditions, including spur cell anemia
(14) and both myotonic muscular dystrophy and congenital
myotonia (6, 8). In the former instance, the fluidity change is
secondary to increased levels of cholesterol in the serum (14).
Unusual lipid serum levels have been reported for CHS (25) as
well as other lipid-related metabolic abnormalities (24, 33).
With these considerations in mind, we elected to study eryth-
rocytes from normal subjects as well as from those suffering
from CHS. We have determined the fluidity characteristics of
intact erythrocytes and the lipid composition of erythrocyte
ghosts,
MATERIALS AND METHODS
Animals
Normal (C576J +/+) mice were obtained from the Jackson Laboratory (Bar
Harbor, Maine). CHS mice (C576J bg/bg) were originally obtained from the
same supplier and were maintained in colony at Indiana University School of
Medicine Animal Facility. Adult male animals were used for all experiments.
They were fed Wayne Lab Blox (Allied Mills, Inc., Castleton, Ind.). Weights
were 25-27 g for C57 animals and 22-27 gfor CHS mice.
Human Subjects
One white female patient, age 4 yr, was studied. Thediagnosis of CHS had
been established by clinical history and examination and by the presence ofgiant
lysosomes in PMN (5). 8 wk before the present studies, ascorbic acid treatment
had been discontinued as a check on the continued efficacy of this therapeutic
approach (5). The patient's chiefcomplaint was photophobia secondary to optic
atrophy. Her leukocyte count was 300-500 cells/mm'' and she was free from
infection. No indication of hepatosplenomegaly was observed. Cells from three
normal white adult females were used as controls.
Erythrocyte and Ghost Preparation
For ESRstudies, heparinizedvenous blood wasobtained from human subjects;
heparinized blood was obtained by cardiac puncture from mice. Blood samples
from 10-15 animals were pooled before subsequent steps in erythrocyte prepa-
ration were taken. After centrifugation (2,500 g, 10 min, 4°C), the serum and
bufiy coat were aspirated. The pellet was washed three times in phosphate-
buffered saline (PBS), pH 7.4. The supernate as well as the upper 3 mm of the
erythrocyte pellet were aspirated with each wash to reduce the number of
contaminating leukocytes. The final erythrocyte pellet was suspended at 50%
hematocrit in PBS and held on ice. In someexperiments, the RBCwere incubated
with 0.01 M ascorbate for 15 min at 25°C, washed in 0.9% NaCl, and suspended
in PBS.
For ghost preparation, heparinized human venous blood was used. Heparin-
ized blood was obtained from mice by cardiac puncture. Blood samples from 40-
50 animals were pooled before subsequent steps in erythrocyte ghost preparation
were carried out. Erythrocytes were washed three times in 20 mM NaP0,, pH
7.4, containing 125 mM NaCl as described above. Then ice-cold 20 mM phos-
phate buffer, pH 7.4, was added to the washed erythrocyte pellet and centrifu-
gation was carried out at 17,000 g, 20 min, 4°C. The supernate was aspirated and
the tube rotated at an angle to allow the erythrocyte ghost pellet to slide away
from the underlying smallerpellet ofleukocyteswhich was also aspirated. Washes
in 20 mM phosphate were repeated until the ghost pellet was white. Then three
washes in 20 mM NaP04, pH 7,4, containing 125 mM NaCl were performed.
Samples of erythrocyte ghosts were held on ice for later protein analysis by the
method of Lowry (27). The remaining material was immediately extracted for
lipid analysis.
Lipid Analysis
Lipids were extracted from erythrocyte ghosts (1.0-1 .5 mg of protein) (18)
with CHCl:CH,OH (2:1 vol/vol) containing0.0005% butylated hydroxytoluene .
The Folch-washed (18) CHCI, extract was analyzed for total cholesterol, total
lipid phosphorus, fatty acid composition, and phospholipid head group compo-
sition. Analysis of cholesterol content was performed by the enzymatic method
based on cholesterol oxidase and cholesterol ester hydrolase (Boehringer Mann-
heim Biochemicals, Indianapolis, Ind.) (35). Total lipid phosphorus was deter-
mined as described (I1).
Analysis of fatty acid composition was performed by gas-liquid chromatog-
raphy. Asample oflipid extract was subjected to alkaline hydrolysis with 1.2 N
KOH in 80% ethanol for 60 min at 57°C (1). Fatty acids in the saponifiable
fraction were methylated (29) and the methyl esters separated, using a Hewlett-
Packard 5710A gas chromatograph (Hewlett-Packard Co., Palo Alto, Calif.)
equipped with a 1.8 m 10% SP-2340 on 100-200 mesh chromosorb column. Peaks
were identified by comparison of retention times to those of standard fatty acids
(Supelco, Inc., Bellefonte, Pa.). Classes of phospholipids were separated by thin-
layer chromatography (TLC) using plates prewashed in ethyl acetate and devel-
oped in CHCI,:CH,OH: CH3000H:H2O (100:50:142:6) (39). Spots correspond-
ing to location of known standards were scraped and analyzed for phosphorus
content. The Student's t test was used to determine the statistical significance of
differences detected in the lipid content of normal and CHS erythrocytes.
ESR
The doxyl-substituted analogue of stearic acid, 2-(3-carboxypropyl)-4,4-di-
methyl-2-tridecyl-3-oxazolidinyloxyl (SDS), was obtained from Syva (Palo Alto,
Calif.). A stock solution at 5 mM was made in ethanol and stored at 4°C. 3 lrl of
5DSstock solution was added to the bottom of a glass tube (13 x 100 mm). The
solvent was evaporated with dry nitrogen gas. A 100-1al sample of erythrocyte
suspension was added and vortexed briefly. After 5 min at 25°C the labeled
erythrocytes were transferred to a 100-Ial glass capillary. Oneend ofthe capillary
was heat-sealed and the erythrocytes were centrifuged into this end (1,000 g, 2
min, 25°C). For experiments in which erythrocytes were treated with ascorbate
(10 mM final concentration), the erythrocyte suspension was diluted 10-fold in
0.9% sodium chloride and centrifuged before spin-labeling of the erythrocyte
pellet. ESR signal intensity ofthese samples indicated no significant reduction of
spin label by the ascorbate.
ESR spectra were obtained on a standard balanced-bridge spectrometer with
diode detection operating at 9.1 GHzat 23° or 25°C. In our hands, the change
in order parameter as a function of temperature is - 0.007/°C. First derivative
absorption spectra were recorded with a 100-G field sweep, a scan time of 10
min, a peak-to-peak modulation amplitude of 1.5 G and a time constant of0.5
s. Other instrument settings and data analyses were done as previously described
(21). In brief, the order parameter (S), a measurement of spin-label order and
motion, was calculated (20) from the extrema of the ESR spectrum of 5DS-
labeled erythrocytes (Fig. 1).
where 2TII and 2T' are the distances between outer and inner extrema, respec-
tively, and C= 1.4 - 0.053(Ti - T'). As flexibility of the hydrocarbon chain of
the spin label decreases, the order parameter increases. This implies that as the
environment surrounding the nitroxide group ofthe label becomes more ordered
(i.e., less fluid), the order parameter increases. The theoretical limits of S are
S = 0 for a completely fluid, isotropic system and S= 1 for a completely rigid or
ordered environment. Typical values for spin-labeled membranes are from 0.5 to
0.7. For experiments in which identical samples were run on the same day, the
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FIGURE 1 First derivative ESR spectrum at 25°C of 5DS-labeled
erythrocytes from a CHS patient. The hyperfine splitting parameters
2Ti, and 2T1are the separation between outer and inner extrema,
respectively, and are used in the calculation of order parameter.
INGRAHAM ET AL .
￿
Chediak-Higashi Erythrocyte Fluidity and Fatty Acids
￿
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samples were measured and data from several days were available, a two-way
analysis of variance was carried out. All P values given herein are for the
probability that a null hypothesis is true .
RESULTS
Membrane Fluidity of Erythrocytes
The order parameter (S), a measure of membrane fluidity,
was obtained from the ESR spectra of erythrocytes labeled
with 5DS . Erythrocytes obtained from normal and CHS mice
were compared at 23°C (Fig. 2). S for the CHS cells (0.653)
was lower than for normal ones (0.661) . Analysis of variance
showed that the difference was highly significant (P< 0.001) .
A similar comparison was done at 25°C for human eryth-
rocytes (Fig. 3). A difference was again detected between
normal and CHS erythrocytes: S was 0.684 for normals but for
the CHS patient it was 0.675 (P < 0.001) . Thus, in both mice
and humans, CHS erythrocytes have greater membrane fluidity
in the bilayer region probed by 5DS .
Previous work has shown that the abnormally low S values
for CHS leukocytes could be restored to normal by treatment
with 10 mM ascorbate (21) . Similar effects of ascorbate were
found herein for erythrocytes. In vitro ascorbate treatment (10
mM) for 15 min before spin-labeling with 5DS gave S values
for CHS erythrocytes that were not significantly different from
those for normal cells in both humans (P > 0.99) and mice
(P > 0.80) (Figs . 2 and 3).
Cholesterol, Phospholipid, and Protein Content
of Normal and CHS Erythrocyte Ghosts
Table I gives molar ratios ofcholesterol/phospholipid (chol/
PL) for chloroform extracts of erythrocyte ghosts from mice
FIGURE 2 Order parameters at 23°C for 5DS-labeled erythrocytes
from normal and CHS mice . Incubation and labeling conditions are
described in Materials and Methods. Final concentration of ascor-
bate was 0,01 M . Bars indicate 2 SE abovethe mean . Values are from
analysis of 12 or more samples from three separate experiments . P
values are for the probability that a null hypothesis comparing the
indicated values is true .
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FIGURE 3 Order parameter at 25°C for 5DS-labeled erythrocytes
from three normal humans and the CHS patient . Incubation and
labeling conditions are described in Materials and Methods. Final
concentration of ascorbatewas 0.01 M. Bars indicate 2 SE abovethe
mean . Values are from analysis of nine or more samples from three
separate experiments . P values are for the probability that a null
hypothesis comparing the indicated values is true .
and humans . The CHS cells of humans had a lower chol/PL
than normals, whereas the reverse was true of erythrocytes
from mice . The differences between CHS and control eryth-
rocytes are statistically significant for mice (P< 0.03), but not
for humans (P < 0.15) .
Table I also gives ratios on a weight basis for phospholipid/
protein (PL/prot). In both species, the abnormal cells had
relatively higher amounts ofphospholipid than did the normal
erythrocytes . However, these differences are probably not sig-
nificant (P < 0.15).
Phospholipid Composition of
Erythrocyte Ghosts
The phospholipid composition of erythrocyte ghosts from
mice and humans is given in Table 11 . Statistical analysis
suggested that only the differences in phosphatidy1choline (PC)
were significant (P < 0.03 for mice, P < 0.04 for humans) . We
also compared the ratios of sphingomyelin (SP)/PC and PC/
phosphatidylethanolamine(PE) . For humans the SP/PC ratio
is increased in the CHS (from 0.55 to 0.62, P < 0.06), whereas
in mice this ratio is decreased (from 0.21 to 0.15, P < 0.049).
Mice showed increased PC/PE ratios in the CHS extracts;
however, this increase was not statistically significant .
Fatty Acid Composition of Erythrocyte Ghosts
The percents of different fatty acids and of monoenoic and
polyenoic vs. saturated fatty acids are given in Table III .
Among the differences detected was a relatively higher pro-
portion of polyunsaturated fatty acids in CHS erythrocytes of
both humans and mice as compared with the respective control
values for each species . In human cells, polyenoic fatty acids
account for 35 .5% of total fatty acids in normal erythrocytes
but are increased to 48.3% in CHS erythrocytes (P < 0.01) .Among the individual fatty acids that are increased in CHS
are 20:4 (from 7.1 to 16.2%, P < 0.001) and 18:2 (from 7 .4 to
12.5%, P < 0.001). Likewise in the mouse, polyenoic fattyacids
increase from 39.4 to 47 .4% (P < 0.025) for CHS erythrocytes.
Again, increases are seen in 20:4 (10.7 to 14.8%, P < 0.02) and
18:2 (8.3 to 12.6%, P < 0.001). Mice also have a significant
increase in 22:6 (from 4.1 to 8.4, P < 0.005). The increases in
18:2 and 20:4 for both mouse and human CHS subjects may
reflect the relation between the two fatty acids; 18:2 is a
precursor for 20:4. As would be expected from the above
described fatty acid differences, the average number of double
bonds is increased in CHS erythrocytes for both humans (P <
0.03) and mice (P < 0.04). Note that in the instance of human
subjects there was a large difference in the unidentified (other)
categories for normal and CHS. However, it is unlikely that
the differences in percent polyenoic fattyacids are attributable
to this large difference in "other" fatty acids, because most
"other" fatty acids in the normal human subject were eluted
from the column before any polyunsaturated fatty acids.
DISCUSSION
Our results show that, regardless of species, the spin-label 5DS
has greater freedom of molecular movement in CHS erythro-
cyte membranes than in normal cells. We have previously
TABLE I
Comparison of Cholesterol, Phospholipid, and Protein
Content of Normal and CHS Erythrocyte Ghosts
Cholesterol/phospho- Phospholipid/protein
Erythrocyte
￿
lipid (molar ratio)
￿
(Ag/mg)
* Average and SEM of triplicate determinations on erythrocyte ghosts of one
normal subject.
$ Range of values.
§ Average of duplicate determinations on cells of one CHS patient.
~~ Average and SEM of triplicate determinations carried out on erythrocyte
ghosts prepared from pooled blood samples collected from 40-50 mice.
TABLE II
demonstrated a similar difference between normal and CHS
PMN (21). The order parameter, which varies inversely with
fluidity, is lower in CHS cells. The lipid analyses show differ-
ences in erythrocyte ghost composition between normal and
CHS cells; some ofthese differences correlate with the observed
differences in fluidity.
Table IV shows changes in lipid composition that would be
expected to promote greater freedom ofmolecular motion (i.e.,
greater fluidity) in membranes. These changes include de-
creased chain length of fatty acids, increased degree of unsat-
uration of fatty acids, decreased amount of cholesterol relative
to phospholipid (chol/PL), increased amount of phospholipid
relative to protein (PL/prot), decreased amount of SP relative
to PC, and increased amount of PC relative to PE. Thus, for
example, on the basis of our lipid analyses one could have
predicted that normal mouse erythrocyte membranes would be
more fluid than those from humans. Compared to human
erythrocytes, mouse erythrocytes have lower average fatty acid
chain length, higher degree of unsaturation of fatty acids,
decreased chol/PL, increased PL/prot, decreased SP/PC, and
increased PC/PE (Tables I-III). All these differences are con-
sistent with order parameters that are lower for mouse eryth-
rocytes than for human; our ESR results verify that such a
difference between species exists. For mouse cells S = 0.647
(23*C data corrected to 25°C), whereas for human cells S =
0.684 at 25°C. Such variations in membrane fluidity of similar
cells from different species are expected. Smallbut significant
differences in phospholipid distribution, fatty acid composi-
tion, and protein content among species have been demon-
strated (42), and this difference contributes to the interspecies
membrane fluidity variations.
In light of the above considerations, comparison of lipid
composition in normal and CHS cells within a single species
might yield valuable information about the contribution that
specific lipid membrane constituents may be making to the
abnormal fluidity characteristics of CHS cells. Mouse CHS
erythrocytes have membranes more fluidthan controls. Among
the statistically significant variations in lipid composition that
may contribute to this difference are: increased degree of fatty
acid unsaturation (P < 0.04) and decreased SP/PC (P < 0.049).
These factors evidently dominate the two that are inconsistent
with a more fluid environment: increased average chain length
(P < 0.05) and increased chol/PL (P < 0.03). Human CHS
erythrocyte membranes also are more fluid than those of
normal cells. The statistically significant difference in lipid
composition consistent with this result is an increased degree
of fatty acid unsaturation (P < 0.03). Inconsistent with the
* U, unidentified ; LPC, lysophosphatidylcholine; SP, sphingomyelin; PC, phosphatidylcholine; PS,phosphatidylserine; Pl, phosphatidylinositol; PE, phosphatidyl-
ethanolamine.
$ Average and SEM of triplicate determinations on erythrocyte ghosts of onenormal subject.
§ Percentage of total recovered phospholipids.
~~ Average of duplicate determination on cells of one CHS patient.
Average and SEM of triplicate determinations on erythrocyte ghosts prepared from pooled blood samples collected from 40-50 mice.
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Erythrocyte U*
Phospholipid
LPC
Percentage Composition
SP
of Erythrocyte Ghosts
PC PS + PI PE
HUMAN
Normal$ 1 .3§ ± 0.3 2.7 ±0.4 19.5 ± 0.3 35.5±0.7 15 .6±1.4 25.4±1 .8
CHS11 2.8 3.7 20.7 33.3 15.8 23.7
MOUSE
Norman 0.7 ± 0.1 2.2 ± 0.2 9.2 ± 0.1 43.5 ±1 .1 16.5±0.5 27.9±1 .2
CHS$ 1 .4 ±0.6 1.7±0.6 7.1 ± 1 .8 47.4±0.8 15.0±1.7 27.4±1 .0
HUMAN
Normal*
CHS§
0.54 ± 0.04
(0.50-0.61)$
0.49
696 ± 52
(635-799)
789
(0.46-0.52) (755-824)
MOUSE
Norma(JJ 0.33 ± 0.03 878 f 56
(0.28-0.37) (772-960)
CHS11 0.42 ± 0.01 948 ± 38
(0.40-0.44) (891-1,019)greater fluidity is the increased SP/PC (P < 0.06).
It is not surprising that in the abnormal cells we find lipid
differences that would tend to decrease fluidity along with
other differences that would tend to have the opposite effect.
Because membrane fluidity is apparently important in cell
functions such as maintenance of permeability characteristics
and activity of membrane-associated enzymes, it is likely that
fluidity properties for individual species are maintained within
relatively narrow limits. If the cell had fluidity properties
outside this range it might be unable to survive. Recent studies
of mutant Chinese hamster ovary cells with defective choles-
terol biosynthesis support this view (40). Cholesterol accumu-
lates in the membranes of these cells. This abnormality, which
would tend to decrease fluidity, is offset by increases in oleic
acid and in PC/PE, and these cells have order parameters
similar to those of normal cells, despite the change in choles-
terol composition (40).
In selecting the lipid differences that might account for the
greater fluidity ofCHS erythrocytes, we have made the follow-
ing assumption: the important differences relative to CHS
defects are presumably those present both in humans and in
the mouse model system. The one difference that is consistent
with greater membrane fluidity and that is found regardless of
species is an increased degree of fatty acid unsaturation. This
alteration in the average number of fatty acid double bonds in
the lipids derived from erythrocytes of normal and CHS mice
or humans can account for the observed differences in mem-
brane fluidity. Gaffney (19) has shown that a 10% increase in
the number of unsaturated fatty acid chains can result in a
significant change in membrane fluidity. Her studies were
carried out in a model bilayer system of synthetic dioleoyl and
diarachidonoyl lecithins. An increase in the amount of diar-
achidonoyl lecithin increased the average number of double
bonds by 0.3 and increased the bilayer fluidity (decreased the
order parameter) by ---0.01 . In the present study, we observed
increases in membrane fluidity (decreases in the order param-
eter) of 0.009 and 0.008, concomitant with increases in the
average number of double bonds of 0.32 and 0.25 for humans
and mice, respectively. Our results do not rule out the possi-
bility that other factors, such as lipid-protein interactions or
membrane-cytoskeletal interactions, may also contribute to the
observed fluidity differences. However, it is clear that the
detected change in degree of saturation can account for the
observed fluidity change.
Fatty acid composition of membranes is profoundly influ-
encedby diet (17, 45). Our lipidanalysis ofhumanerythrocytes,
obtained by comparing one normal control to one CHS patient,
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TABLE III
FattyAcids of Erythrocyte Ghosts
Fatty acids
' Average and SEM of triplicate determinations on erythrocyte ghosts of one normal subject.
$ Percentage of total fatty acid.
§ Average of duplicate determinations on erythrocyte ghosts of one CHS patient.
11 -None detected.
I Average and SEM of triplicate determinations on erythrocyte ghosts prepared from pooled blood samples collected from 40-50 mice.
may be influenced, therefore, by dietary differences between
the two subjects. Neither the control nor the patient was on a
specialized diet at the time of the study. However, the normal
and CHS mice received comparable diets and dietary contri-
butions should be minimized in the animal data. Further, these
data were obtained on pooled samples from 40-50 individual
animals. Accordingly, we conclude that the increased degree
of fatty acid unsaturation is a factor contributing to the more
fluid membranes detected in CHS erythrocytes.
It appears from our data that the humanerythrocyte is more
rigid normally than is that of the mouse. We have previously
shown that the same is true for the PMN from the two species
(21). We do not see this as being incompatible with normal cell
function in one or the other species. When a cell such as a
PMN is called upon to perform, the absolute value of S may
not be as important as the change in S value that occurs. The
expected normal range of S values could be the same for both
species although the absolute values encompassed by that range
are different. A fluidity abnormality would probably be ex-
pressed as impaired function if that abnormality makes recep-
tors unavailable for interaction with their specific ligands or if
it prevents fluidity changes that normally accompany a cell's
function. We suggest that one or more of these possibilities
may be true for CHS PMN.
Our observation that both PMN (21) and erythrocytes of
CHS have abnormal fluidity indicates that CHS pathophysi-
ology may relate to a general membrane abnormality. The
giant granules of CHS cells may result from a tendency to
membrane fusion that would be expected for membranes con-
taining relatively greater amounts of unsaturated fatty acids
(28). Furthermore, higher unsaturated fatty acid content may
make these cells more susceptible to lipid peroxidation. The
return to more normal fluidity values with ascorbate treatment
may occur because of ascorbate-mediated peroxidation (16, 31)
rather than from a "correction" of a basic membrane defect.
That such normalization is important to the cell's function is
suggested by the improved chemotaxis of CHS PMN treated
with ascorbate (5). The greater fluidity of CHS membranes
may also result in receptors for chemoattractants being rela-
tively less exposed for combination with their specific ligands
(2, 4). Unavailability of these receptors could account, at least
in part, for poor chemotactic responsiveness. The ascorbate
treatment, by rigidizing the membrane, could therefore bring
about displacement of these receptors so that they are more
exposed, and although ascorbate does not repair the underlying
abnormality its net effect is therapeutic.
No erythrocyte abnormality has previously been reported
Erythrocyte 12:0 12:0 14:0 16:0 16:1 18:0 18:1 18:2 18:3 20:2 20:3
HUMAN
Normal` 2.210.7$ 3.2±0.9 2.2±0.1 13.410.2 2.2±0.1 8.9±0.2 16.0±0.3 7.4 ± 0.1 5.5±0.3 3.710.6 3.8±0.2
CHS§ 0.2 0.4 0.3 14.7 0.2 15.1 17.1 12.5 2.4 1 .3 3 5
MOUSE
NormalT 0.410.2 1.4±0.4 1.110.2 21 .3±0.2 2.0±0.1 10.5±0.4 17.8±1.2 8.3 ± 0.2 3.9 1 0.1 1.2 ± 0.1 3.5 ± 0.1
CHST 0.2±0.1 0.1±0.1 0.6±0.3 23.811.3 0.6±0.1 11.1±0.6 12.8±0.6 12.6 ± 0.1 2.5 1 0.9 - 10 , 01Fatty acids
TABLE IV
* Material in parentheses denotes quantitative measure of compo-
sition change; T, increase; 1, decrease.
for CHS. This does not, however, preclude the possible impor-
tant contribution of increased fluidity to the pathology of the
syndrome. The erythrocyte (unlike the PMN) possesses no
granules, does not undergo rapid ameboid movement, and is
not a chemotactically responsive cell. Therefore, the erythro-
cyte may perform all of its functions normally despite the
fluidity increase, whereas the PMN, because of its specialized
role in host defense, is impaired in its physiologic responses.
The abnormal membrane fluidity detected in CHS PMN
(21) and in CHS erythrocytes reported herein suggests that a
generalized membrane abnormality may be associated with the
disease. Precedents for this concept are known. In spur-cell
anemia, an increased cholesterol content of erythrocyte and
platelet membranes is reflected in a decreased membrane fluid-
ity (14). Several inherited neurological disorders are also as-
sociated with abnormal erythrocyte membranes. An increased
erythrocyte membrane fluidity was observed in myotonic mus-
cular dystrophy and congenital myotonia (8). Abnormalities in
the lateral diffusion of 5DS (43), in a lipid-protein interaction
(37), and in the physical state of membrane proteins (7) have
been observed in RBC membranes in Duchenne muscular
dystrophy. In Huntington's disease, alterations in the physical
state of erythrocyte membrane proteins (9) and in erythrocyte
deformability (10) were found. Thus, in these several examples,
as well as in the CHS, the presence of the disease is associated
with an alteration in erythrocyte membranes.
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